A common point of opposition to offering buprenorphine in correctional settings is the perceived risk of diversion, disciplinary issues, or safety concerns created by allowing access to buprenorphine.
Vital Strategies supported technical assistance to six county jails in Pennsylvania that had been funded by the Commonwealth to expand access to buprenorphine to incarcerated persons.
This snapshot looks at the reported incidence of diversion, assault, and conduct citations at the six jails in Pennsylvania that together provided buprenorphine to more than 1,000 individuals over an 18 month period through this state-funded grant program.
A Call to Action: Air Pollution in Early Childhood
Infectious Disease Detection Capabilities of Southeast Asian Countries: A Landscape Analysis of Surveillance…
Atitudes e percepções sobre a infância e violência contra crianças e adolescentes no…
An Observational Study of the Implementation of the Tobacco-Free Film and Television Policy…
Expanding First Response for Health Emergencies
Funding for Harm Reduction Programs
A Prosecutor’s Guide to Advancing a Public Health Response to Drug Use.
Quick Reference Guide and Checklist for CRVS and ID Systems Improvement Framework
Tobacco Control Case Study: Vietnam – E-Cigarette Message Testing Guides Policymaking
Public Opinion Poll Results on Alcohol Consumption in Sri Lanka